@ErinGillespieMD presents a provocative phase II RCT of prophylactic #radiotherapy to asymptomatic but high risk bone Mets. N=93 Convincing home run, 29% vs 1.6% skeletal related events, with an ⬆️ OS benefit! Remained significant…https://t.co/oSDocBgdc1 https://t.co/1k8AS962m2
The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning
https://t.co/252VWkya81
#Radiology#RadOnc#Radiotherapy@DrKevinChiu